Abstract
A new study reveals that in drastic contrast to other cancer types, translocation renal cell carcinoma (tRCC) is transcriptionally rewired towards an oxidative phosphorylation (OXPHOS) state, which renders tRCC vulnerable to interventions that promote NADH-reductive stress, highlighting how the maintenance of the optimal redox state in cancer can be therapeutically exploited.